The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York PDF) Emerging Use of BPC 157 in Orthopaedic Sports Medicine: A Systematic Review Is BPC 157 Banned? Oral vs. Injectable Forms Explained FDA moves toward easing restrictions on certain peptides BioPharma Dive